{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:29:19Z","timestamp":1770964159229,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s30949","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T03:51:19Z","timestamp":1367985079000},"page":"401","source":"Crossref","is-referenced-by-count":8,"title":["Ambrisentan for the treatment of pulmonary arterial hypertension: improving outcomes"],"prefix":"10.2147","author":[{"given":"Joe","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Elshaboury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,5]]},"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=16024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:20:34Z","timestamp":1477866034000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/ambrisentan-for-the-treatment-of-pulmonary-arterial-hypertension-impro-peer-reviewed-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ppa.s30949","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}